Lannett News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.09.17	Lannett's Board Of Directors Initiates CEO Search (PR Newswire)
06.09.17	MDXG Revises Q3 Outlook, Two Down, One To Go For BLPH, TECH Opens Wallet (RTTNews)
05.09.17	Lannett Receives Approval For Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg And 40 mg (PR Newswire)
05.09.17	Technical Snapshots for These Generic Drugs Stocks -- Catalyst Pharma, Flexion Therapeutics, Supernus Pharma, and Lannett (PR Newswire)
28.08.17	Suneva Medical Expands their Prestigious Board of Directors with the Appointment of Vince Ippolito (PR Newswire)
24.08.17	AZRX To Report Data In Sep., Long & Short Of PETS, IMUC Plunges, CLDX On Watch (RTTNews)
23.08.17	Lannett Reports Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Provides Guidance For Fiscal 2018 (PR Newswire)
08.08.17	Lannett Announces Preliminary Fiscal 2017 Fourth-Quarter And Full-Year Financial Results, Comments On Fiscal 2018 Outlook (PR Newswire)
01.08.17	Lannett To Present At The Canaccord Genuity 37th Annual Growth Conference On August 9 (PR Newswire)
31.07.17	How These Generic Drugs Stocks are Performing? -- Akari Therapeutics, Flexion Therapeutics, Lannett, and Supernus Pharma (PR Newswire)
17.07.17	Lannett Appoints Samuel H. Israel As General Counsel (PR Newswire)
14.07.17	Lannett Receives Approval For Cyproheptadine Hydrochloride Syrup, 2 mg/5 mL (PR Newswire)
26.06.17	Lannett Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitartrate And Acetaminophen Tablets USP (PR Newswire)
22.06.17	Lannett Receives Approval For Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5 mg/300 mg, 7.5 mg/300 mg And 10 mg/300 mg (PR Newswire)
20.06.17	Lannett Names Patrick G. LePore To Board of Directors (PR Newswire)
19.06.17	Lannett Receives Approval For Niacin Extended-Release Tablets USP, 500 Mg And 1000 Mg (PR Newswire)
07.06.17	Generic Drugs Stocks on Investors' Radar -- Catalyst Pharma, Lannett, Evoke Pharma, and Galectin Therapeutics (PR Newswire)
16.05.17	Lannett Announces Approval For Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL (0.5 mg/mL) (PR Newswire)
09.05.17	Lannett Voluntarily Pays Down Remaining $25 Million Principal Balance Of Revolving Credit Facility (PR Newswire)
03.05.17	Harwood Feffer LLP Announces Investigation of RetailMeNot, Inc. (PR Newswire)
28.04.17	Lannett To Participate At Three Investor Conferences In May (PR Newswire)
24.04.17	How These Generic Drugs Stocks are Faring? -- Evoke Pharma, Neurocrine Biosciences, Lannett, and Catalent (PR Newswire)
11.04.17	Freedonia Analyst Weighs in on Pesticides and the EPA (PR Newswire)
30.03.17	Lannett Voluntarily Pays Down Additional $25 Million Of Revolving Credit Facility (PR Newswire)
17.03.17	How These Generic Drugs Stocks are Faring? -- Neurocrine Biosciences, Lannett, Rigel Pharma, and Catalent (PR Newswire)
27.02.17	Lannett To Participate At Four Upcoming Investor Conferences (PR Newswire)
23.02.17	Lannett Announces Addition To Management Team (PR Newswire)
22.02.17	Lannett Provides Further Update On Methylphenidate ER Tablets (PR Newswire)
07.02.17	Lannett Announces Successful Completion Of ERP System Extraction (PR Newswire)
01.02.17	Lannett Reports Fiscal 2017 Second-Quarter Financial Results (PR Newswire)
30.01.17	Generic Drugs Stocks on Investors' Radar -- Ironwood Pharma, Medicines, Rigel Pharma, and Lannett (PR Newswire)
26.01.17	SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of Lannett Company, Inc. -LCI (PR Newswire)
25.01.17	Lannett To Report Fiscal 2017 Second-Quarter Financial Results, Host Conference Call On Wednesday, February 1 (PR Newswire)
23.01.17	Lannett Voluntarily Pays Down $75 Million Of Revolving Credit Facility (PR Newswire)
19.01.17	Lifshitz & Miller Law Firm Announces Investigation of Ally Financial Inc., Amphastar Pharmaceuticals, Inc., Lannett Company, Inc., Live Ventures Incorporated, MiMedx Group, Inc., Seattle Genetics,... (PR Newswire)
13.01.17	Harwood Feffer LLP Announces Investigation of Lannett Company Inc. (PR Newswire)
13.01.17	Bernstein Liebhard LLP Announces That Only Four Days Remain To File A Motion For Lead Plaintiff In A Class Action Suit Against Lannett Company, Inc. (PR Newswire)
12.01.17	EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Lannett Company, Inc. - LCI (PR Newswire)
20.12.16	How These Generic Drugs Stocks are Faring? -- Ironwood Pharma, Medicines, Lannett, and SCYNEXIS (PR Newswire)
17.12.16	SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Lannett Company, Inc. To Contact The Firm Before Lead Plaintiff Deadline (PR Newswire)
07.12.16	Lannett To Participate At Two Investment Conferences In December (PR Newswire)
28.11.16	Lannett Announces Approval For Metaxalone Tablets USP, 800 Mg (PR Newswire)
04.11.16	ACHN Tanks, INNL's Acts Fail, LCI In The Crosshair Of Law, ONCE Loses Its Spark (RTTNews)
28.10.16	CEMP Plunges, ALDR Promises Data In 1H 2017, AERI Withdraws NDA, AZN, CYH Abuzz (RTTNews)
21.10.16	Mallinckrodt plc -- Moody's: FDA Proposal to withdraw generic Concerta from the market would be negative for Lannett and Mallinckrodt (Moodys)
19.10.16	Lannett: FDA To Withdraw Approval Of ANDA For Methylphenidate ER Tablets (RTTNews)
19.09.16	Lannett Says FDA Completes CGMP Inspections Of Three Facilities - Quick Facts (RTTNews)
24.08.16	LCI Vaults On Bright Outlook, OSUR Gets Zika Contract, CLVS To Face FDA In Feb. (RTTNews)
15.06.16	Lannett Company, Inc. -- Moody's Affirms Lannett's B2 CFR; Senior Secured Rating Downgraded to B2; Stable outlook (Moodys)
22.04.16	Lannett To Co-Develop Generic Insulin Product For U.S. Market (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Lannett Co Inc Registered Shs (Old)

Aktien Top/Flop

Meistgelesene Nachrichten